Related Experiment Video
Updated: Jun 16, 2026
09:47
Analysis of Histone Antibody Specificity with Peptide Microarrays
Published on: August 1, 2017
Antibody fragments: hope and hype
1Tufts University School of Medicine, Boston, MA, USA. aaron.lowell.nelson@gmail.com
Mabs
|January 23, 2010
Summary
Novel antibody fragments like antigen-binding fragments (Fab) and single chain variable fragments (scFv) are advancing. However, current data show limited distinct clinical properties based solely on fragment size.
Area of Science:
- Biotechnology
- Immunology
- Pharmaceutical Sciences
Background:
- Antibody molecules are modular, allowing for extraction of specific domains.
- A new wave of antigen-specific antibody therapeutics is emerging for clinical evaluation.
Purpose of the Study:
- To examine the developmental histories of antibody-derived therapeutics.
- To categorize different types of recombinant antibody fragments and their applications.
Main Methods:
- Literature review of antibody fragment technology.
- Analysis of recombinant antibody fragment types: antigen-binding fragments (Fab), single chain variable fragments (scFv), and third-generation (3G) fragments.
- Investigation of multi-specificity and conjugation strategies in antibody fragments.
Main Results:
- Three main types of antibody fragments (Fab, scFv, 3G) represent successive technological advancements.
- Drug developers are exploring multi-specificity and conjugation for all fragment types.
- Few data currently demonstrate distinct clinical properties of antibody fragments solely due to size.
Conclusions:
- While antibody fragments offer therapeutic potential, clinical differentiation based on size remains largely unproven.
- The field is advancing with novel fragment designs and modifications.
- Further clinical data are needed to establish unique performance characteristics of different antibody fragment formats.
Related Concept Videos
01:31Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
01:10Antibody Structure
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
01:10Antibody Structure
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
01:26Antibody Actions
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
01:25Antibody Structure and Classes
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
01:41Affinity and Avidity
Overview